Health Care

Commentary

American Healthcare Broken? Says Who?

A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
Biosimilars

The Biosimilar Promise

Biosimilars Often Reduce Prices by 50 Percent or More

Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden  | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
Commentary

A British Lord’s Warning: Steer Clear of Single-Payer Healthcare

Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Commentary

Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion

Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Climate Change

Learn how municipal climate change lawsuits hurt consumers

Bonta’s legal war on energy companies will punish ordinary Californians

Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Commentary

Learn how PBMs pocket savings intended for patients

How Long Can Pharmacy Benefit Managers Go Unchecked?

Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Commentary

Read about the Trump and Harris health care plans

Trump Has a Plan for Healthcare

Harris, by contrast, has been mum on whether she continues to support a government takeover of the health insurance system as she did during her first run for the presidency. Instead, she has said that she wants to strengthen the Affordable Care Act and extend President Joe Biden’s ruinously expensive scheme ...
Commentary

Learn about the latest problems with Obamacare

Americans Don’t Want Obamacare’s High Maintenance

At last week’s presidential debate, Vice President Kamala Harris was asked about her previous support for Medicare For All, a $44 trillion proposal that would outlaw private insurance. She backed away from the questions, saying, “What we need to do is maintain and grow the Affordable Care Act.” Read the full ...
Blog

Learn how drug price controls hurt patients, innovation

Senator Sanders’ Price Controls Will Harm Patients

In a patently politicized press release, Senator Bernie Sanders (I-VT) who is  Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Commentary

Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.

Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...
Commentary

American Healthcare Broken? Says Who?

A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
Biosimilars

The Biosimilar Promise

Biosimilars Often Reduce Prices by 50 Percent or More

Biosimilars Often Reduce Prices by 50 Percent or More By Wayne Winegarden  | October 1, 2024 READ PDF Executive Summary In the competitive biologic markets, biosimilars have reduced average prices by 56 percent. The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though ...
Commentary

A British Lord’s Warning: Steer Clear of Single-Payer Healthcare

Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Commentary

Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion

Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Climate Change

Learn how municipal climate change lawsuits hurt consumers

Bonta’s legal war on energy companies will punish ordinary Californians

Neither are heroic efforts to safeguard the environment. The former will primarily harm families by worsening the nation’s pervasive affordability problems. The second is a clear effort to extract “multiple billions” from ExxonMobil while maximizing political optics in a state where the majority of voters will support anything they are ...
Commentary

Learn how PBMs pocket savings intended for patients

How Long Can Pharmacy Benefit Managers Go Unchecked?

Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Commentary

Read about the Trump and Harris health care plans

Trump Has a Plan for Healthcare

Harris, by contrast, has been mum on whether she continues to support a government takeover of the health insurance system as she did during her first run for the presidency. Instead, she has said that she wants to strengthen the Affordable Care Act and extend President Joe Biden’s ruinously expensive scheme ...
Commentary

Learn about the latest problems with Obamacare

Americans Don’t Want Obamacare’s High Maintenance

At last week’s presidential debate, Vice President Kamala Harris was asked about her previous support for Medicare For All, a $44 trillion proposal that would outlaw private insurance. She backed away from the questions, saying, “What we need to do is maintain and grow the Affordable Care Act.” Read the full ...
Blog

Learn how drug price controls hurt patients, innovation

Senator Sanders’ Price Controls Will Harm Patients

In a patently politicized press release, Senator Bernie Sanders (I-VT) who is  Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Commentary

Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.

Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...
Scroll to Top